Acumen Pharmaceuticals Debt Issuance/Retirement Net - Total 2020-2025 | ABOS
Acumen Pharmaceuticals debt issuance/retirement net - total from 2020 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
| Acumen Pharmaceuticals Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2024 | $-1 |
| 2023 | $30 |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Biomedical and Genetics | $0.082B | $0.000B |
| Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amgen (AMGN) | United States | $154.892B | 13.19 |
| CSL (CSLLY) | Australia | $67.141B | 0.00 |
| Alnylam Pharmaceuticals (ALNY) | United States | $58.528B | 0.00 |
| Abivax SA (ABVX) | France | $6.124B | 0.00 |
| Alkermes (ALKS) | Ireland | $4.782B | 13.29 |
| CRISPR Therapeutics AG (CRSP) | Switzerland | $4.714B | 0.00 |
| ACADIA Pharmaceuticals (ACAD) | United States | $4.385B | 40.61 |
| ADMA Biologics Inc (ADMA) | United States | $4.119B | 29.76 |
| Ascentage Pharma Group - (AAPG) | China | $3.948B | 0.00 |
| Arcellx (ACLX) | United States | $3.848B | 0.00 |
| Akero Therapeutics (AKRO) | United States | $3.738B | 0.00 |
| Apellis Pharmaceuticals (APLS) | United States | $3.482B | 0.00 |
| Alvotech (ALVO) | Luxembourg | $2.433B | 18.34 |
| Agios Pharmaceuticals (AGIO) | United States | $2.191B | 0.00 |
| ANI Pharmaceuticals (ANIP) | United States | $2.029B | 18.19 |
| Adaptive Biotechnologies (ADPT) | United States | $2.007B | 0.00 |
| Apogee Therapeutics (APGE) | United States | $1.677B | 0.00 |
| Celldex Therapeutics (CLDX) | United States | $1.466B | 0.00 |
| Cogent Biosciences (COGT) | United States | $1.375B | 0.00 |
| AbCellera Biologics (ABCL) | Canada | $1.249B | 0.00 |
| CureVac (CVAC) | Germany | $1.205B | 5.59 |
| CorMedix Inc (CRMD) | United States | $1.107B | 19.77 |
| Arbutus Biopharma (ABUS) | United States | $0.711B | 0.00 |
| Castle Biosciences (CSTL) | United States | $0.696B | 68.60 |
| AnaptysBio (ANAB) | United States | $0.569B | 0.00 |
| Cytek Biosciences (CTKB) | United States | $0.527B | 0.00 |
| Alumis (ALMS) | United States | $0.483B | 0.00 |
| Compass Therapeutics (CMPX) | United States | $0.483B | 0.00 |
| Corvus Pharmaceuticals (CRVS) | United States | $0.428B | 0.00 |
| Absci (ABSI) | United States | $0.357B | 0.00 |
| Abeona Therapeutics (ABEO) | United States | $0.350B | 7.42 |
| ADC Therapeutics SA (ADCT) | Switzerland | $0.345B | 0.00 |
| CytomX Therapeutics (CTMX) | United States | $0.336B | 3.64 |
| Amarin (AMRN) | Ireland | $0.311B | 0.00 |
| Contineum Therapeutics (CTNM) | United States | $0.293B | 0.00 |
| Allogene Therapeutics (ALLO) | United States | $0.251B | 0.00 |
| Alector (ALEC) | United States | $0.238B | 0.00 |
| Annexon (ANNX) | United States | $0.226B | 0.00 |
| Adocia (ADOCY) | France | $0.216B | 0.00 |
| AC Immune (ACIU) | Switzerland | $0.205B | 0.00 |
| Aardvark Therapeutics (AARD) | United States | $0.180B | 0.00 |
| Actuate Therapeutics (ACTU) | United States | $0.175B | 0.00 |
| Caribou Biosciences (CRBU) | United States | $0.174B | 0.00 |
| Citius Oncology (CTOR) | United States | $0.170B | 0.00 |
| Climb Bio (CLYM) | United States | $0.151B | 0.00 |
| Cellectis S.A (CLLS) | France | $0.143B | 0.00 |
| Cardiff Oncology (CRDF) | United States | $0.140B | 0.00 |
| Anika Therapeutics (ANIK) | United States | $0.135B | 0.00 |
| Coherus Oncology (CHRS) | United States | $0.135B | 0.00 |
| Alpha Cognition (ACOG) | Canada | $0.134B | 0.00 |
| Agenus (AGEN) | United States | $0.133B | 0.00 |
| Connect Biopharma Holdings (CNTB) | United States | $0.115B | 0.00 |
| Coya Therapeutics (COYA) | United States | $0.110B | 0.00 |
| Anebulo Pharmaceuticals (ANEB) | United States | $0.103B | 0.00 |
| Adagene (ADAG) | China | $0.100B | 0.00 |
| Alto Neuroscience (ANRO) | United States | $0.100B | 0.00 |
| ANIXA BIOSCIENCES INC (ANIX) | United States | $0.096B | 0.00 |
| CervoMed (CRVO) | United States | $0.089B | 0.00 |
| Applied Therapeutics (APLT) | United States | $0.071B | 0.00 |
| ABVC BioPharma (ABVC) | United States | $0.067B | 0.00 |
| Aligos Therapeutics (ALGS) | United States | $0.065B | 0.00 |
| Adverum Biotechnologies (ADVM) | United States | $0.065B | 0.00 |
| Coeptis Therapeutics Holdings (COEP) | United States | $0.064B | 0.00 |
| ALX Oncology Holdings (ALXO) | United States | $0.063B | 0.00 |
| Adlai Nortye (ANL) | Cayman Islands | $0.062B | 0.00 |
| Cue Biopharma (CUE) | United States | $0.060B | 0.00 |
| Adicet Bio (ACET) | United States | $0.060B | 0.00 |
| Clene (CLNN) | United States | $0.053B | 0.00 |
| Annovis Bio (ANVS) | United States | $0.045B | 0.00 |
| CollPlant Biotechnologies (CLGN) | Israel | $0.033B | 0.00 |
| AN2 Therapeutics (ANTX) | United States | $0.030B | 0.00 |
| Clearside Biomedical (CLSD) | United States | $0.029B | 0.00 |
| Cadrenal Therapeutics (CVKD) | United States | $0.027B | 0.00 |
| Akari Therapeutics (AKTX) | United Kingdom | $0.024B | 0.00 |
| Allarity Therapeutics (ALLR) | United States | $0.023B | 0.00 |
| Cingulate (CING) | United States | $0.022B | 0.00 |
| Curis (CRIS) | United States | $0.021B | 0.00 |
| Abpro Holdings (ABP) | United States | $0.020B | 0.00 |
| Cuprina Holdings (Cayman) (CUPR) | Singapore | $0.019B | 0.00 |
| Adaptimmune Therapeutics (ADAP) | United Kingdom | $0.016B | 0.00 |
| Cocrystal Pharma (COCP) | United States | $0.015B | 0.00 |
| Chemomab Therapeutics (CMMB) | Israel | $0.015B | 0.00 |
| COSCIENS Biopharma (CSCI) | Canada | $0.010B | 0.00 |
| Advanced Biomed (ADVB) | United States | $0.009B | 0.00 |
| Adial Pharmaceuticals (ADIL) | United States | $0.008B | 0.00 |
| Avalon GloboCare (ALBT) | United States | $0.008B | 0.00 |
| Acurx Pharmaceuticals (ACXP) | United States | $0.007B | 0.00 |
| Alzamend Neuro (ALZN) | United States | $0.007B | 0.00 |
| Apollomics (APLM) | United States | $0.004B | 0.00 |
| CNS Pharmaceuticals (CNSP) | United States | $0.004B | 0.00 |
| Aceragen (ACGN) | United States | $0.000B | 0.00 |
| Clovis Oncology (CLVSQ) | United States | $0.000B | 0.00 |